Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Ligand Pharmaceuticals Inc Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	BUY	$65.67 - $77.08 $16,023 - $18,807	244 Added 10.27%	2,621 $192,000
Q4 2022 Feb 07, 2023	BUY	$61.72 - $96.74 $9,258 - $14,511	150 Added 6.74%	2,377 $158,000
Q3 2022 Nov 01, 2022	BUY	$0.01 - $107.56 $1 - $16,026	149 Added 7.17%	2,227 $192,000
Q2 2022 Aug 04, 2022	BUY	$74.52 - $117.06 $42,699 - $67,075	573 Added 38.07%	2,078 $185,000
Q1 2022 May 09, 2022	BUY	$94.99 - $151.56 $14,913 - $23,794	157 Added 11.65%	1,505 $169,000
Q4 2021 Feb 07, 2022	SELL	$127.69 - $165.85 $67,548 - $87,734	-529 Reduced 28.18%	1,348 $204,000
Q2 2021 Aug 06, 2021	SELL	$113.03 - $155.64 $169,431 - $233,304	-1,499 Reduced 44.4%	1,877 $246,000
Q1 2021 May 06, 2021	BUY	$99.52 - $215.83 $112,159 - $243,240	1,127 Added 50.11%	3,376 $515,000
Q4 2020 Feb 09, 2021	BUY	$80.55 - $106.05 $66,212 - $87,173	822 Added 57.6%	2,249 $224,000
Q3 2020 Nov 10, 2020	BUY	$89.56 - $126.72 $985 - $1,393	11 Added 0.78%	1,427 $136,000
Q2 2020 Aug 06, 2020	BUY	$68.28 - $123.65 $12,426 - $22,504	182 Added 14.75%	1,416 $158,000
Q1 2020 May 11, 2020	BUY	$63.37 - $107.88 $11,406 - $19,418	180 Added 17.08%	1,234 $90,000
Q4 2019 Feb 05, 2020	BUY	$96.94 - $113.59 $8,239 - $9,655	85 Added 8.77%	1,054 $107,000
Q3 2019 Nov 12, 2019	BUY	$86.25 - $120.16 $15,352 - $21,388	178 Added 22.5%	969 $96,000
Q2 2019 Aug 08, 2019	SELL	$107.38 - $129.34 $2,254 - $2,716	-21 Reduced 2.59%	791 $90,000
Q1 2019 Apr 26, 2019	BUY	$105.93 - $142.47 $10,487 - $14,104	99 Added 13.88%	812 $102,000
Q4 2018 Feb 08, 2019	BUY	$128.36 - $272.13 $23,104 - $48,983	180 Added 33.77%	713 $95,000
Q3 2018 Nov 13, 2018	BUY	$211.18 - $274.49 $112,558 - $146,303	533 New	533 $146,000

Others Institutions Holding LGND

# of Institutions

255

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.87B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account